-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on MetLife, Lowers Price Target to $98

Benzinga·07/14/2025 13:51:31
Listen to the news
Morgan Stanley analyst Nigel Dally maintains MetLife (NYSE:MET) with a Overweight and lowers the price target from $99 to $98.